QS Investors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $13.6M | Buy |
67,659
+11,126
| +20% | +$2.33M | 0.16% | 95 |
|
|
2021
Q1 | $12.1M | Buy |
56,533
+9,734
| +21% | +$2.14M | 0.14% | 112 |
|
|
2020
Q4 | $11.1M | Buy |
46,799
+3,790
| +9% | +$870K | 0.13% | 124 |
|
|
2020
Q3 | $11.7M | Buy |
43,009
+4,551
| +12% | +$1.26M | 0.16% | 112 |
|
|
2020
Q2 | $11.2M | Sell |
38,458
-406
| -1% | -$110K | 0.16% | 115 |
|
|
2020
Q1 | $9.25M | Buy |
38,864
+500
| +1% | +$115K | 0.15% | 122 |
|
|
2019
Q4 | $8.42M | Buy |
38,364
+3,315
| +9% | +$671K | 0.08% | 180 |
|
|
2019
Q3 | $5.94M | Buy |
35,049
+15,368
| +78% | +$2.72M | 0.06% | 237 |
|
|
2019
Q2 | $3.61M | Buy |
19,681
+300
| +2% | +$52.4K | 0.04% | 373 |
|
|
2019
Q1 | $3.57M | Sell |
19,381
-126
| -0.6% | -$23.3K | 0.04% | 375 |
|
|
2018
Q4 | $3.23M | Sell |
19,507
-6,365
| -25% | -$1.1M | 0.04% | 355 |
|
|
2018
Q3 | $4.99M | Sell |
25,872
-1,940
| -7% | -$345K | 0.05% | 280 |
|
|
2018
Q2 | $4.73M | Buy |
27,812
+2,010
| +8% | +$312K | 0.05% | 306 |
|
|
2018
Q1 | $4.21M | Hold |
25,802
| – | – | 0.04% | 315 |
|
|
2017
Q4 | $3.87M | Buy |
25,802
+5,703
| +28% | +$844K | 0.04% | 381 |
|
|
2017
Q3 | $3.06M | Buy |
20,099
+7,904
| +65% | +$1.19M | 0.02% | 466 |
|
|
2017
Q2 | $1.57M | Sell |
12,195
-2,400
| -16% | -$289K | 0.01% | 651 |
|
|
2017
Q1 | $1.6M | Buy |
14,595
+8,061
| +123% | +$710K | 0.01% | 664 |
|
|
2016
Q4 | $481K | Hold |
6,534
| – | – | ﹤0.01% | 895 |
|
|
2016
Q3 | $570K | Sell |
6,534
-252
| -4% | -$23.8K | ﹤0.01% | 864 |
|
|
2016
Q2 | $584K | Sell |
6,786
-612
| -8% | -$52.9K | 0.01% | 877 |
|
|
2016
Q1 | $588K | Buy |
7,398
+1,108
| +18% | +$100K | 0.01% | 874 |
|
|
2015
Q4 | $791K | Buy |
6,290
+24
| +0.4% | +$2.9K | 0.01% | 830 |
|
|
2015
Q3 | $653K | Sell |
6,266
-1,760
| -22% | -$226K | 0.01% | 845 |
|
|
2015
Q2 | $991K | Buy |
8,026
+1,800
| +29% | +$227K | 0.01% | 761 |
|
|
2015
Q1 | $734K | Hold |
6,226
| – | – | 0.01% | 804 |
|
|
2014
Q4 | $740K | Sell |
6,226
-1,000
| -14% | -$113K | 0.01% | 790 |
|
|
2014
Q3 | $812K | Sell |
7,226
-500
| -6% | -$47.6K | 0.02% | 389 |
|
|
2014
Q2 | $731K | Buy |
7,726
+2,151
| +39% | +$151K | 0.02% | 425 |
|
|
2014
Q1 | $394K | Sell |
5,575
-1,100
| -16% | -$87.1K | 0.01% | 485 |
|
|
2013
Q4 | $496K | Sell |
6,675
-600
| -8% | -$41.8K | 0.02% | 429 |
|
|
2013
Q3 | $551K | Sell |
7,275
-825
| -10% | -$65.6K | 0.02% | 411 |
|
|
2013
Q2 | $654K | Buy |
+8,100
| New | +$597K | 0.02% | 469 |
|
Other funds holding VRTX
QS Investors's VRTX Position: Q2 2021 in Review
QS Investors increased its Vertex Pharmaceuticals (VRTX) stake by 20% in Q2 2021, buying an estimated $2.33M and bringing the position to 67,659 shares worth $13.6M. The position accounts for 0.16% of the portfolio, ranked #95.
QS Investors first reported a position in VRTX in Q2 2013 and has held it in 33 quarters since. 977 funds tracked by Wall St. Rank hold VRTX as of Q2 2021.
- QS Investors held 67,659 shares of Vertex Pharmaceuticals worth $13.6M as of Q2 2021.
- QS Investors bought 11,126 Vertex Pharmaceuticals shares in Q2 2021, an estimated $2.33M.
- Vertex Pharmaceuticals made up 0.16% of QS Investors's portfolio in Q2 2021, its #95 holding.
- QS Investors first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 33 quarters since.
- 977 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2021.
Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.